XJPX
4107
Market cap1.20bUSD
Oct 09, Last price
3,735.00JPY
1D
0.27%
1Q
-1.06%
Jan 2017
51.21%
Name
Ise Chemicals Corp
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
ISE Chemicals Corporation, a company primarily operating in Japan, specializes in the manufacturing, refinement, and distribution of iodine, its various derivatives, and compounds of cobalt and nickel. The company's iodine products are essential for a wide array of applications, including X-ray contrast agents, polarizing film production, disinfectants, catalysts, stabilizers, pharmaceutical ingredients, and diverse nutritional additives for both humans and animals. Its cobalt and nickel compounds are predominantly utilized in the creation of electronic components. Additionally, ISE Chemicals extends its operations to include the extraction and provision of natural gas, supplying it to gas utility companies and industrial facilities. Established in 1927, ISE Chemicals Corporation maintains its headquarters in Tokyo, Japan, and functions as a subsidiary of AGC Inc.
Key people
Executive President, Chief Executive Officer, Representative Director · since 2025
Hideaki Suga
Senior Managing Executive Officer, Chief Director of Administration, Senior Director in Main Administration Unit, Director · since 2022
Hiroaki Ono
Senior Executive Officer, Manager of Corporate Strategy Office · since 2024
Takashi Takayama
Managing Executive Officer, Chief Director of Sales · since 2022
Hideaki Akiyama
Executive Officer, Shirasato Plant Manager in Main Manufacturing Unit · since 2022
Naoki Komata
Executive Officer, Assistant Manager of Corporate Strategy Office · since 2024
Yasutaka Shimizu
Executive Officer, Shirako Plant Manager in Main Manufacturing Unit · since 2025
Michitaka Goto
Director · since 2021
Toshiro Kasuya
Executive President, Representative Director · since 2025
Independent Director · since 2022
Kentaro Shibata
Independent Director · since 2021
Daisuke Soejima
Independent Director · since 2025
Daisuke Soejima
Independent Director · since 2025
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||